MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on March 11, 2008; DOI: 10.1124/mol.107.043406


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.043406v1
73/6/1722    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Author home page(s):
Narendra P Singh
Mitzi Nagarkatti
Prakash Nagarkatti
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singh, N. P
Right arrow Articles by Nagarkatti, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singh, N. P
Right arrow Articles by Nagarkatti, P.


Received for publication November 12, 2007.
Revised March 6, 2008.
Accepted for publication March 7, 2008.

Primary peripheral T cells become susceptible to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD)-mediated apoptosis in vitro upon activation and in the presence of dendritic cells

Narendra P Singh 1, Mitzi Nagarkatti 1, Prakash Nagarkatti 1*

1 University of South Carolina School of Medicine

* Address correspondence to: E-mail: pnagark{at}gw.med.sc.edu

Abstract

While the toxic effects of TCDD on T cells in vivo have been well characterized, attempts to reproduce these findings in vitro have not been successful. In the current study, we examined whether activation or the presence of dendritic cells (DCs) would make primary naïve T cells from C57BL/6 mice susceptible to TCDD-induced apoptosis in vitro. While nonactivated primary T cells cultured with TCDD (10-1000 nM) were relatively resistant to apoptosis, they became sensitive to apoptosis upon activation with ConA. Moreover, ConA-activated T cells cultured in the presence of DCs showed highest levels of TCDD-induced apoptosis. Similarly, primary T cells from OT II.2a mice cultured with specific Ova peptide and syngeneic DCs showed higher levels of apoptosis when compared to similar nonactivated T cells. T cell activation led to upregulation of AhR, Fas, and FasL expression. Also, DC maturation and culture with TCDD caused significant induction of FasL. TCDD-mediated apoptosis in activated peripheral T cells was AhR-dependent. Analysis of why nonactivated T cells are more resistant while activated T cells are sensitive to TCDD-induced apoptosis revealed that TCDD treatment of activated but not nonactivated T cells led to down-regulation of c-FLIP an inhibitor of apoptosis. Moreover, down-regulation of c-FLIP using siRNA in unactivated T cells made them sensitive to TCDD-induced apoptosis. The current study demonstrates for the first time that TCDD can induce apoptosis in vitro in peripheral T cells upon activation and in the presence of DCs and that this may be mediated by down-regulation of c-FLIP.


Key words: Fluorescence techniques, Ah receptor, Apoptosis, DNA damage and repair





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics